Differential susceptibility: implications for epidemiology, risk assessment, and public policy.
Brown
S L
SL
Environ Corporation, Washington, DC.
D000107:Acetylation; D000818:Animals; D001560:Benzidines / Q000009:adverse effects*; D002274:Carcinogens, Environmental / Q000009:adverse effects; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D007538:Isoniazid / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D010641:Phenotype; D011110:Polymorphism, Genetic; D012307:Risk Factors; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D001560:Benzidines; D002274:Carcinogens, Environmental; C029876:benzidine; D007538:Isoniazid